Temporal N-glycoproteomic differences between COVID-19 survivors and non-survivors at hospital admission and beyond.
COVID-19 has proven to have a wide range of symptoms in human patients, prompting investigation into relevant biomarkers and underlying biological mechanisms. In this study, we aimed to develop a robust quantitative N-glycoproteomics approach for complex plasma samples and to characterize the altered glycosylation prof...